Literature DB >> 18502260

The association of endogenous sex hormones with lipoprotein subfraction profile in the Multi-Ethnic Study of Atherosclerosis.

Dhananjay Vaidya1, Adrian Dobs, Susan M Gapstur, Sherita Hill Golden, Arlene Hankinson, Kiang Liu, Pamela Ouyang.   

Abstract

The traditional lipid profile differs by sex hormone levels. However, associations of sex hormones with lipoprotein subfractions, which may more accurately represent metabolic pathways to atherosclerosis, are not well studied. We quantified the cross-sectional associations of endogenous sex hormones with lipoprotein subfractions in 3143 men and 2038 postmenopausal women who were not on hormone replacement therapy, aged 45 to 84 years, in the Multi-Ethnic Study of Atherosclerosis baseline examination. Particle sizes and numbers of very low-density (VLDL), low-density (LDL), and high-density (HDL) lipoproteins were measured by nuclear magnetic resonance. In both men and women, after multivariable adjustment, higher sex hormone binding globulin (SHBG) levels are associated with smaller, fewer VLDL; larger, fewer LDL; and larger, more numerous HDL particles, whereas higher endogenous estradiol levels are associated with smaller VLDL and smaller, more numerous HDL and LDL particles (all P < .05). Testosterone (adjusted for SHBG) is associated with smaller VLDL particles in men but not women (sex difference P = .040). Higher dehydroepiandrosterone levels are associated with more numerous, smaller VLDL particles only in women (sex difference P = .030, .004, respectively). In conclusion, we found sex differences in the association of endogenous androgens with lipoprotein particle sizes and numbers. Higher endogenous estradiol, but lower SHBG, is associated with a more atherogenic lipoprotein particle profile. These findings highlight the potential to improve the lipoprotein profile with sex hormones, but emphasize the intricacies of the interactions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502260      PMCID: PMC4017356          DOI: 10.1016/j.metabol.2008.01.019

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  32 in total

1.  Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women.

Authors:  Gavin J Blake; James D Otvos; Nader Rifai; Paul M Ridker
Journal:  Circulation       Date:  2002-10-08       Impact factor: 29.690

Review 2.  Measurement issues related to lipoprotein heterogeneity.

Authors:  James D Otvos; Elias J Jeyarajah; William C Cromwell
Journal:  Am J Cardiol       Date:  2002-10-17       Impact factor: 2.778

3.  Relationship between insulin resistance, sex hormones and sex hormone-binding globulin in the serum lipid and lipoprotein profiles of Japanese postmenopausal women.

Authors:  S Kumagai; Y Kai; H Sasaki
Journal:  J Atheroscler Thromb       Date:  2001       Impact factor: 4.928

4.  Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.

Authors:  Helen M Colhoun; James D Otvos; Mike B Rubens; M R Taskinen; S Richard Underwood; John H Fuller
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

5.  Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.

Authors:  I R Pirwany; R Fleming; I A Greer; C J Packard; N Sattar
Journal:  Clin Endocrinol (Oxf)       Date:  2001-04       Impact factor: 3.478

6.  Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women.

Authors:  D Goodman-Gruen; E Barrett-Connor
Journal:  Diabetes Care       Date:  2000-07       Impact factor: 19.112

7.  LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Samia Mora; Moyses Szklo; James D Otvos; Philip Greenland; Bruce M Psaty; David C Goff; Daniel H O'Leary; Mohammed F Saad; Michael Y Tsai; A Richey Sharrett
Journal:  Atherosclerosis       Date:  2007-05       Impact factor: 5.162

Review 8.  Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease.

Authors:  F Labrie; V Luu-The; S X Lin; J Simard; C Labrie; M El-Alfy; G Pelletier; A Bélanger
Journal:  J Mol Endocrinol       Date:  2000-08       Impact factor: 5.098

9.  Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  S S Soedamah-Muthu; Y-F Chang; J Otvos; R W Evans; T J Orchard
Journal:  Diabetologia       Date:  2003-05-13       Impact factor: 10.122

10.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

View more
  20 in total

1.  Lipoprotein subclasses and endogenous sex hormones in women at midlife.

Authors:  Samar R El Khoudary; Maria M Brooks; Rebecca C Thurston; Karen A Matthews
Journal:  J Lipid Res       Date:  2014-05-22       Impact factor: 5.922

2.  Endogenous Sex Steroid Hormones, Lipid Subfractions, and Ectopic Adiposity in Asian Indians.

Authors:  Catherine Kim; Shengchun Kong; Ronald M Krauss; Frank Z Stanczyk; Srinivasa T Reddy; Belinda L Needham; Alka M Kanaya
Journal:  Metab Syndr Relat Disord       Date:  2015-10-02       Impact factor: 1.894

3.  Testosterone and the metabolic syndrome.

Authors:  Vakkat Muraleedharan; T Hugh Jones
Journal:  Ther Adv Endocrinol Metab       Date:  2010-10       Impact factor: 3.565

Review 4.  Gender differences in cardiovascular disease: hormonal and biochemical influences.

Authors:  Faustino R Pérez-López; Luis Larrad-Mur; Amanda Kallen; Peter Chedraui; Hugh S Taylor
Journal:  Reprod Sci       Date:  2010-06       Impact factor: 3.060

5.  Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis.

Authors:  Mariana Lazo; Irfan Zeb; Khurram Nasir; Russell P Tracy; Matthew J Budoff; Pamela Ouyang; Dhananjay Vaidya
Journal:  Clin Gastroenterol Hepatol       Date:  2015-01-13       Impact factor: 11.382

6.  Trajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopause.

Authors:  Samar R El Khoudary; Nanette Santoro; Hsiang-Yu Chen; Ping G Tepper; Maria M Brooks; Rebecca C Thurston; Imke Janssen; Sioban D Harlow; Emma Barinas-Mitchell; Faith Selzer; Carol A Derby; Elizabeth A Jackson; Daniel McConnell; Karen A Matthews
Journal:  Eur J Prev Cardiol       Date:  2015-09-18       Impact factor: 7.804

7.  Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study.

Authors:  Charles X Kim; Kent R Bailey; George G Klee; Allison A Ellington; Guanghui Liu; Thomas H Mosley; Hamid Rehman; Iftikhar J Kullo
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

8.  An update on testosterone, HDL and cardiovascular risk in men.

Authors:  Arthi Thirumalai; Katya B Rubinow; Stephanie T Page
Journal:  Clin Lipidol       Date:  2015

Review 9.  Challenges to the measurement of estradiol: an endocrine society position statement.

Authors:  William Rosner; Susan E Hankinson; Patrick M Sluss; Hubert W Vesper; Margaret E Wierman
Journal:  J Clin Endocrinol Metab       Date:  2013-03-05       Impact factor: 5.958

Review 10.  Vascular Pathways of Testosterone: Clinical Implications.

Authors:  Margarida Lorigo; Melissa Mariana; Nelson Oliveira; Manuel C Lemos; Elisa Cairrao
Journal:  J Cardiovasc Transl Res       Date:  2019-12-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.